百度(09888.HK)自動駕駛將採用NVIDIA系統級芯片Orin
內媒報道,百度(09888.HK)的第三代自動駕駛平臺ACU產品「三鮮」,將搭載使用NVIDIA系統級芯片Orin,預期在搭載並實現量產後,三鮮自動駕駛計算平臺將覆蓋全域自動駕駛場景,同時支持百度ANP城市領航輔助駕駛。
報道指,NVIDIA DRIVE Orin可提供每秒254萬億次運算(TOPS),藉助可擴展的DRIVE Orin 產品系列,開發者只需在整個車隊中構建、擴展和利用一次開發投資,便可從L2+級系統一路升級至L5級全自動駕駛汽車系統。
百度方面表示,本次三鮮所搭載的Orin芯片,有助於提升百度自動駕駛的性能及安全性,同時有助未來實現量產與提升用戶駕乘體驗。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.